“Type 3 diabetes” is an informal term some researchers use to describe the connection between insulin resistance and Alzheimer’s disease. While not an official medical diagnosis, growing evidence suggests that the same metabolic problems behind type 2 diabetes may also drive cognitive decline and dementia.
What Is Type 3 Diabetes?
The term “type 3 diabetes” was first proposed by researcher Suzanne de la Monte at Brown University in 2005. Her groundbreaking research demonstrated that the brain produces its own insulin, and when this insulin signaling breaks down, it may trigger the hallmark changes seen in Alzheimer’s disease.
Unlike type 1 diabetes (where the body cannot produce insulin) and type 2 diabetes (where cells become resistant to insulin), type 3 diabetes refers specifically to insulin resistance in the brain. This brain-specific insulin resistance appears to contribute to the formation of amyloid plaques and neurofibrillary tangles — the two defining features of Alzheimer’s disease.
It is important to note that the medical community has not officially adopted “type 3 diabetes” as a clinical diagnosis. You will not find it in diagnostic manuals, and your doctor would not use this term on a chart. However, the underlying science connecting diabetes and dementia is strong enough that researchers continue to study the relationship seriously.
The Science Behind the Connection
Your brain is one of the most energy-demanding organs in your body, consuming roughly 20% of your total glucose supply. Insulin is not just about blood sugar — in the brain, it supports memory formation, neuron survival, and the communication between brain cells (synaptic plasticity).
When brain cells become resistant to insulin, several damaging processes begin:
- Amyloid plaque buildup: Insulin-degrading enzyme (IDE) normally breaks down both insulin and amyloid-beta protein. When insulin levels are chronically high, IDE gets overwhelmed handling insulin and cannot clear amyloid-beta effectively.
- Tau protein tangles: Insulin resistance leads to overactivation of an enzyme called GSK-3β, which causes tau proteins to become hyperphosphorylated and form tangles inside neurons.
- Chronic inflammation: Elevated blood sugar triggers neuroinflammation, damaging brain cells over time.
- Reduced blood flow: Damaged blood vessels from prolonged high blood sugar reduce oxygen and nutrient delivery to the brain.
De la Monte’s research showed that postmortem brains of Alzheimer’s patients had dramatically reduced insulin and insulin receptor levels, even in patients without a prior diabetes diagnosis. This suggested the brain was experiencing its own form of diabetes, independent of what was happening in the rest of the body.
How Diabetes and Prediabetes Affect Dementia Risk
The statistical connection between diabetes and dementia is substantial. According to a meta-analysis published in the Journal of Diabetes Investigation, people with type 2 diabetes have approximately a 60% higher risk of developing dementia compared to those without diabetes. The risk applies to both Alzheimer’s disease and vascular dementia.
Even prediabetes may pose risks. Chronically elevated blood sugar — even at levels below the diabetes threshold — can damage brain blood vessels and promote low-grade inflammation that harms neurons over years and decades.
| Metabolic Condition | Estimated Increased Dementia Risk | Primary Brain Effects |
|---|---|---|
| Normal blood sugar | Baseline | Normal insulin signaling |
| Prediabetes | ~18-20% higher | Early vascular changes, mild inflammation |
| Type 2 diabetes (controlled) | ~40-60% higher | Insulin resistance, vascular damage |
| Type 2 diabetes (uncontrolled) | ~60-120% higher | Severe insulin resistance, plaque buildup, brain atrophy |
Key Studies and Findings
Several landmark studies have shaped our understanding of the diabetes-dementia connection:
The Rotterdam Study (1999)
This large population-based study followed nearly 7,000 older adults and found that those with type 2 diabetes had nearly double the risk of developing dementia. It was one of the first major studies to establish the epidemiological link.
De la Monte’s Brain Insulin Research (2005-2008)
Suzanne de la Monte and her team at Brown University demonstrated that Alzheimer’s brains showed dramatically reduced expression of genes for insulin and insulin-like growth factors. They coined the term “type 3 diabetes” and showed that the brain’s own insulin production could fail independently of the pancreas.
The ACCORD-MIND Trial (2011)
This trial examined whether intensive blood sugar control could slow cognitive decline in people with type 2 diabetes. While results were mixed, the study provided important data showing that diabetes duration and severity correlated with brain volume loss.
Intranasal Insulin Studies (2012-Present)
Researchers have experimented with delivering insulin directly to the brain through nasal spray. Early results showed modest improvements in memory and cognition in people with mild cognitive impairment and early Alzheimer’s, supporting the idea that brain insulin deficiency contributes to the disease.
Risk Factors That Overlap
Diabetes and Alzheimer’s share many of the same risk factors, which further supports the connection between the two conditions:
- Obesity: Excess body fat promotes systemic inflammation and insulin resistance throughout the body, including the brain.
- Sedentary lifestyle: Physical inactivity worsens insulin sensitivity and reduces blood flow to the brain.
- Poor diet: Diets high in processed sugars and refined carbohydrates contribute to both conditions.
- Cardiovascular disease: High blood pressure and high cholesterol damage brain blood vessels.
- Age: Risk for both conditions increases significantly after age 65.
- Genetics: The APOE4 gene variant increases risk for both Alzheimer’s and metabolic syndrome.
Understanding your A1C levels is an important step in assessing your metabolic health and, potentially, your long-term brain health.
Warning Signs to Watch For
If you have diabetes or prediabetes, be aware of cognitive changes that might indicate early problems:
- Forgetting recent conversations or events more often than usual
- Difficulty concentrating or making decisions
- Getting lost in familiar places
- Struggling to find the right words during conversation
- Trouble managing finances or following instructions
- Mood or personality changes
These symptoms can have many causes, but if you notice a pattern, bring it up with your doctor. Early detection of cognitive changes allows for earlier intervention.
What You Can Do to Protect Your Brain
The good news about the diabetes-dementia connection is that many of the same strategies that help manage blood sugar also support brain health. Here is what the research suggests:
Manage Your Blood Sugar
Keeping blood sugar within a healthy range reduces the metabolic stress on your brain. If you have prediabetes, reversing it through lifestyle changes may significantly lower your long-term dementia risk.
Exercise Regularly
Physical activity improves insulin sensitivity in both the body and the brain. Studies show that 150 minutes of moderate aerobic exercise per week can reduce dementia risk by 30% or more. Exercise also stimulates the release of brain-derived neurotrophic factor (BDNF), which supports neuron growth and survival.
Follow a Brain-Healthy Diet
The Mediterranean and MIND diets — both rich in vegetables, whole grains, healthy fats, and lean protein — have been shown to reduce dementia risk. These dietary patterns also help with blood sugar control, creating a dual benefit. Explore diet and nutrition strategies that support both goals.
Monitor Cardiovascular Health
High blood pressure, high cholesterol, and smoking all damage brain blood vessels. Addressing these risk factors protects both your heart and your brain.
Stay Mentally and Socially Active
Cognitive stimulation through learning, puzzles, reading, and social interaction builds cognitive reserve — your brain’s resilience against damage. While this does not directly address insulin resistance, it may delay the onset of symptoms.
Current Research and Future Directions
The type 3 diabetes hypothesis has opened several promising research avenues:
- GLP-1 receptor agonists: Diabetes drugs like liraglutide and semaglutide are being studied for potential neuroprotective effects. Some early trials have shown reduced brain atrophy and improved cognition.
- Intranasal insulin: Ongoing clinical trials are testing whether delivering insulin directly to the brain can slow Alzheimer’s progression.
- Metformin studies: Some observational studies suggest that long-term metformin use may be associated with lower dementia risk, though results remain mixed.
- Lifestyle intervention trials: Large-scale studies like the FINGER trial have shown that comprehensive lifestyle interventions (diet, exercise, cognitive training, vascular risk management) can improve cognitive function in at-risk populations.
While no treatment currently targets “type 3 diabetes” specifically, these studies suggest that metabolic interventions may eventually play a role in Alzheimer’s prevention and treatment.
The Bottom Line
Type 3 diabetes is not a formal medical diagnosis, but the science connecting insulin resistance to Alzheimer’s disease is compelling and growing. The same metabolic dysfunction that drives type 2 diabetes — insulin resistance, chronic inflammation, and vascular damage — appears to affect the brain in ways that promote dementia. The practical takeaway is encouraging: many of the steps you take to manage blood sugar and treat prediabetes may also protect your brain. If you have diabetes, prediabetes, or risk factors for either, talk to your doctor about a comprehensive plan that addresses both metabolic and cognitive health.
